GLP-1 Analogues Market Set to Surpass USD 211.8 Billion by 2035 as Demand for Diabetes and Obesity Therapies Accelerates
The global GLP-1 analogues market is witnessing remarkable growth as the burden of type 2 diabetes and obesity continues to rise worldwide. Valued at US$ 51.6 billion in 2024, the market is projected to reach US$ 211.8 billion by 2035, registering a robust CAGR of 13.7% during the forecast period from 2025 to 2035. This impressive expansion reflects the growing adoption of GLP-1 receptor...
0 Comments 0 Shares 3 Views 0 Reviews